Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sweet solution: sugars to the rescue.

Hudson H Freeze1

  • 1The Burnham Institute, La Jolla Cancer Research Center, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA. hudson@burnham.org

The Journal of Cell Biology
|August 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient iPSC-Derived Cartilage Organoids Reveal Defective ECM Deposition and Altered Chondrogenic Trajectory in Saul-Wilson Syndrome.

bioRxiv : the preprint server for biology·2026
Same author

Targeted long-read RNA sequencing for rare disease diagnosis and variant interpretation.

Science advances·2026
Same author

A homozygous nonsense variant in the oligosaccharyltransferase complex gene, RPN1, causes a congenital disorder of glycosylation.

HGG advances·2026
Same author

Autosomal dominant <i>HK1</i>-related neurodevelopmental disorder with visual defects and brain anomalies (NEDVIBA): An emerging mitochondrial disorder.

Genetics in medicine open·2025
Same author

SLC35A2 loss-of-function variants affect glycomic signatures, neuronal fate and network dynamics.

Brain : a journal of neurology·2025
Same author

Bi-allelic UGGT1 variants cause a congenital disorder of glycosylation.

American journal of human genetics·2025
Same journal

A pan-vertebrate signaling motif controls the molecular function of intracellular AQP12.

The Journal of cell biology·2026
Same journal

Synergistic assembly, disassembly, and protection of complex forms of bundled F-actin.

The Journal of cell biology·2026
Same journal

Recruitment and release of XPG during NER is controlled by pre- and post-incision factors and EXO1.

The Journal of cell biology·2026
Same journal

Meiotic CENP-C supports centromere assembly and kinetochore recruitment in spermatogenesis.

The Journal of cell biology·2026
Same journal

Phosphatidylserine and RhoB connect PI4P and PA metabolism to maintain plasma membrane identity.

The Journal of cell biology·2026
Same journal

PIKfyve influences inter-organelle contacts with lysosomes to modulate the endoplasmic reticulum.

The Journal of cell biology·2026
See all related articles

Dietary fucose supplementation rescues designer mice lacking GDP-Fucose synthesis. This highlights unknown genetic factors influencing survival in metabolic pathways.

Area of Science:

  • Biochemistry
  • Genetics
  • Developmental Biology

Background:

  • GDP-Fucose is essential for glycosylation, a critical post-translational modification.
  • Mice engineered to lack GDP-Fucose synthesis exhibit severe developmental defects and lethality.
  • The role of GDP-Fucose in mammalian development is not fully understood.

Purpose of the Study:

  • To investigate if dietary supplementation can rescue the lethal phenotype in mice unable to synthesize GDP-Fucose.
  • To explore the underlying mechanisms of GDP-Fucose salvage and its impact on survival.
  • To identify potential genetic factors influencing the response to fucose supplementation.

Main Methods:

  • Generation of genetically engineered mice with a deficiency in GDP-Fucose synthesis.

Related Experiment Videos

  • Administration of dietary fucose to assess its rescue potential.
  • Analysis of survival rates and developmental phenotypes in supplemented and control groups.
  • Exploration of genetic modifiers through comparative analysis.

    • Main Results:

    • Dietary fucose supplementation successfully rescued the lethal phenotype in mice lacking GDP-Fucose synthesis.
    • Supplemented mice exhibited improved survival and partially restored development.
    • Significant variability in rescue efficacy suggests the involvement of unknown genetic factors.
    • The salvage pathway effectively utilizes dietary fucose to meet cellular demands.

    Conclusions:

    • Dietary fucose can rescue the essential requirement for GDP-Fucose synthesis, demonstrating the plasticity of glycosylation pathways.
    • Genetic background plays a crucial role in determining the outcome of metabolic interventions.
    • This study identifies a novel therapeutic strategy for conditions related to GDP-Fucose deficiency and underscores the importance of genetic context in metabolic rescue.